With such a profound impact on the TME mediated by OVs, we hypothesized that local infection with a vaccinia virus expressing the IL-15 superagonist (IL-15/IL-15Rα) would lead to enhanced presence of tumor-specific T cells that could be recovered for adoptive transfer, advancing the therapeutic role of ACT for solid tumors. Here, IL15 is linked to infection.